What lipoprotein (a) levels are safe?
High lipoprotein (a) levels are a risk factor for heart disease. Heart disease is the #1 killer in USA and the whole world. Hence taking appropriate steps to lower lp a levels helps you from the risk of having a heart attack. You should know what these normal levels of lipoprotein (a) and what levels are dangerous!
LP(a) molecules are similar to LDL cholesterol structurally but differ in chemical and physical properties.
A level of lp (a) levels increases your risk of coronary heart disease by an incredible 200 to 300% even if your good and bad cholesterol levels are normal.
Normal Lipoprotein (a) range
Approximate levels of risk are indicated by the results below, although at present there are a variety of different methods by which to measure Lp(a). A standardized international reference material has been developed and is accepted by the WHO Expert Committee on Biological Standardization and the International Federation of Clinical Chemistry and Laboratory Medicine. Although further standardization is still needed, development of a reference material is an importance step towards standardizing results.
Desirable : < 14 mg/dL (< 35nmole/l)
Borderline risk : 14 – 30 mg/Dl ( 35 – 75 mmole/l)
High Risk : 31 – 50 mg/dL (75 – 125 mol/l)
Very high risk : >50 mg/Dl ( 125mmol/l)
Lower lipoprotein (a)
If you have high levels of lp (a) take immediate steps to lower lp(a) levels. Nutritional therapy is quite useful for lowering lp(a) levels.
1) Wikipedia, “lipoprotein (a) levels” accessed on 19th May 2013, www.en.wikipedia.com;
2) Marcovina SM, Albers JJ, Scanu AM, Kennedy H, Giaculli F, Berg K, Couderc R, Dati F, Rifai N, Sakurabayashi I, Tate JR, Steinmetz A (2000). “Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)”. Clin. Chem. 46 (12): 1956–67.
3) Dati F, et al (2004). “First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay–Lp(a) SRM 2B”. Clin Chem Lab Med 42 (6): 670–6.